Chronic Conditions, Dermatology, Diabetes & Obesity (Manchester)
This meeting has been organised by CliniLink Ltd and is supported by the pharmaceutical industry via the purchase of exhibition stands. The sponsoring companies have had no involvement in the development of the agenda or content of this meeting.
Further information about the sponsorship can be found below.
See Sponsors below
£0.00
FACE TO FACE EVENT
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: Royal Nawaab Stockport Pyramid Yew Street
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 09:30-09:50 | Registration, Networking and Coffee | |
| 09:50-10:00 | Introduction and welcome | |
| 10:00-10:45 | Sun Damage & Actinic Keratosis: Recognition and Management in Primary Care Recognising actinic keratosis and sun-damaged skin across different skin tones what to look for and when to act Management options in primary care - from topical treatments to cryotherapy and when to refer Understanding malignant transformation risk identifying the actinic keratosis patients who need urgent dermatology review | Dr Stephanie Gallard |
| 10:45-11:15 | Sponsored session | |
| 11:15-11:45 | Break | |
| 11:45-12:30 | When Headache Meets Weight: Recognising the Patterns We Miss Idiopathic intracranial hypertension: the obesity-linked diagnosis often missed in primary care, when to suspect it, red flags, referral pathways Migraine and metabolic syndrome: how obesity, insulin resistance and sleep apnoea worsen migraine frequency and severity Medication overuse headache in patients on multiple chronic disease therapies Emerging role of GLP-1 agonists in migraine prevention (early signal, useful for sponsor relevance) Practical assessment and red flag review for primary care | Dr Mohamed Elnaggar |
| 12:30-13.30 | Lunch | |
| 13.30-14:00 | Sponsored session | TBC |
| 14:00-14:45 | Acne in All Skin Tones: A Primary Care Guide Understanding how acne presents differently across skin tones why it is frequently missed or mismanaged in darker skin types Managing post-inflammatory hyperpigmentation the acne complication that matters most to patients with skin of colour Practical treatment pathways - topical, systemic, and when to refer, with a focus on inclusive, evidence-based prescribing | Dr Stephanie Gallard |
| 14:45-15-00 | Break | |
| 15:00-16:00 | The New NG28: Dual Therapy First-Line and the End of Glucocentric Care Understanding the new NG28 guidelines - what has changed, why it matters, and what it means for your prescribing today Moving beyond HbA1c -treating cardiovascular, renal, and metabolic risk alongside blood sugar in type 2 diabetes Implementing dual therapy first-line in practice patient selection, drug choice, and navigating polypharmacy in complex patients | Dr Mohamed Elnaggar |
Study Day Summary
This dynamic, CPD-accredited study day brings together leading experts in dermatology, endocrinology, and metabolic medicine to explore the growing impact of obesity and chronic disease in everyday primary care practice. With a focus on practical, evidence-based learning, delegates will leave equipped with clinical skills and confidence to apply directly to their patients.
The day covers essential topic areas:
- Dermatology in practice - recognition and management of sun damage, actinic keratosis, and acne across all skin tones
- Neurology and metabolic health - understanding the obesity-headache connection, IIH, and migraine in chronic disease patients
- Diabetes and prescribing - implementing the new NG28 dual therapy guidelines and moving beyond glucocentric care
Learning Outcomes
By the end of this study day, participants will be able to:
- Recognise and manage sun-damaged skin and actinic keratosis across all skin tones, and identify patients requiring urgent dermatology review
- Identify obesity-linked neurological presentations including idiopathic intracranial hypertension and metabolic migraine, and apply appropriate red flag and referral pathways
- Diagnose and manage acne across diverse skin tones, including post-inflammatory hyperpigmentation, using inclusive and evidence-based treatment pathways
- Apply the new NG28 dual therapy guidelines confidently in practice, moving beyond glucocentric care to address cardiovascular, renal, and metabolic risk in type 2 diabetes
Key Benefits
- Practical, clinically relevant content delivered by specialist speakers with primary care expertise
- Peer discussion and networking in a collaborative learning environment
- CPD-accredited certificate for revalidation portfolios
Additional Information
- This is a face-to-face, CPD-accredited event
- A certificate of attendance will be issued for full participation
- Suitable for GPs, prescribing pharmacists, nurses, and wider primary care MDT members
Meet the Speakers
Dr Mohamed Elnaggar
MD, MSc, PhD, MRCP London, MRCP Endo Endocrinologist/Diabetologist SCOPE certified for Obesity Management. Acute Medicine Consultant
Dr Stephanie Gallard
BSc (Hons) Pharmacy, MBChB, Dip Prac Derm, MSc Healthcare Management
She works as a GP with Special Interest in Dermatology within the Liverpool Integrated Clinical Assessment and Treatment Service and contributes to regional teledermatology services. She is active in professional organisations, serving on the executive committee of the Primary Care Dermatology Society and as a non-consultant member of the British Association of Dermatologists.
Stephanie is a passionate educator and regularly lectures for the Royal College of General Practitioners, the Royal Pharmaceutical Society, and other training programmes. Her current focus includes developing dermatology strategy across Cheshire and Merseyside, improving patient pathways, and advancing teledermatology at scale.